AUSTRALIAN-LISTED digital medicines management company MedAdvisor has announced a new partnership with Adheris Health, a US patient adherence and engagement company, to accelerate its roll-out to the US market (PD breaking news Fri).
The initial arrangement is a 12-month "Digital Partnership Agreement", under which Adheris Health will promote and jointly sell MedAdvisor-powered digital adherence programs in the US to its existing pharmaceutical clients as an extension of its current suite of patient performance solutions.
Adheris currently reaches more than 197 million patients on behalf of 26,000+ pharmacies and claims the largest network for patient and prescriber access in the US.
As well as the 197 million patients, there are 295,000 prescribers engaged, giving access to 2.2 billion prescriptions per year.
The main additions to Adheris' suite are MedAdvisor's SMS and web-based offerings.
MedAdvisor will charge a setup fee as well as the per patient fee relating to the size and complexity of the campaign.
MedAdvisor Welam US President Keith Kiaris commented, "The resulting combination will be an unmatched multidimensional approach to patient support in the US, a market more than 10 times the size of Australia".
MedAdvsior CEO Robert Read added that this partnership deal had been brewing for six months and both parties have hopes of an ongoing relationship.
Revenue from the combined efforts will be derived on a per patient, per communication basis and is expected to begin in during the current calendar year.
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Mar 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Mar 19